Search filters

List of works by Paulo Lucio

Activity of the clinical-stage CK2-specific inhibitor CX-4945 against chronic lymphocytic leukemia.

scientific article published on 8 August 2013

BIOMED-1 Concerted Action report: Flow cytometric characterization of CD7+ cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL)

scientific article published on 28 April 2000

BIOMED-1 concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings

scientific article published on 26 July 2001

CD123 hiDendritic Cell Lymphoma: An Unusual Case of Non-Hodgkin Lymphoma

scientific article published on 5 October 1999

Chimeric antigen receptor T-cell therapy for multiple myeloma: a consensus statement from The European Myeloma Network

scientific article published on 22 August 2019

Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma

scientific article published on 12 December 2017

Detection of fusion genes at the protein level in leukemia patients via the flow cytometric immunobead assay ⬇️

scientific article published on November 3, 2010

Economic analysis of rituximab in combination with cyclophosphamide, vincristine and prednisolone in the treatment of patients with advanced follicular lymphoma in Portugal

scientific article published on November 2010

Effects of Delta1 and Jagged1 on early human hematopoiesis: correlation with expression of notch signaling-related genes in CD34+ cells

scientific article published on 12 January 2006

Efficacy and safety of lenalidomide in relapse/refractory multiple myeloma—Real life experience of a tertiary cancer center

scientific article published on 20 July 2014

EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes

scientific article

Expression of adhesion molecules in chronic B-cell lymphoproliferative disorders ⬇️

scientific article published on February 1, 1998

Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL

scientific article published on 01 March 1999

Flow cytometric immunobead assay for fast and easy detection of PML-RARA fusion proteins for the diagnosis of acute promyelocytic leukemia

scientific article

Flow cytometric immunobead assay for the detection of BCR-ABL fusion proteins in leukemia patients.

scientific article

Haploidentical cord blood transplant contaminated with maternal T cells in a patient with advanced leukaemia

scientific article published in May 1996

Health-related quality-of-life results from the phase 3 OPTIMISMM study: pomalidomide, bortezomib, and low-dose dexamethasone versus bortezomib and low-dose dexamethasone in relapsed or refractory multiple myeloma

scientific article published on 09 April 2020

Immunophenotypical detection of minimal residual disease in acute leukemia.

scientific article

Large-volume leukaphereses may be more efficient than standard-volume leukaphereses for collection of peripheral blood progenitor cells

scientific article published in October 1997

Minimal residual disease in adolescent (older than 14 years) and adult acute lymphoblastic leukemias: early immunophenotypic evaluation has high clinical value.

scientific article

Multiple myeloma in elderly patients-a Portuguese multicentric real-life study

scientific article published on 08 April 2019

On CK2 regulation of chronic lymphocytic leukemia cell viability.

scientific article

Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial

scientific article published on 10 December 2019

Quality assessment program for EuroFlow protocols: summary results of four-year (2010-2013) quality assurance rounds

scientific article published on 23 October 2014

Targeting CK2 overexpression and hyperactivation as a novel therapeutic tool in chronic lymphocytic leukemia.

scientific article

Targeting chronic lymphocytic leukemia using CIGB-300, a clinical-stage CK2-specific cell-permeable peptide inhibitor.

scientific article published on January 2014

[Monoclonal gammopathies of indetermined significance: diagnosis and clinical follow-up guidelines]

scientific article published on 01 September 2014

Paulina is supported by:

About Paulina

Help